|
Volumn 2, Issue 12, 2006, Pages 649-653
|
Drug discovery through industry-academic partnerships
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATRASENTAN;
CISPLATIN;
DARUNAVIR;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
EMTRICITABINE;
FINGOLIMOD;
NEW DRUG;
PREZISTA;
PROTEINASE INHIBITOR;
RECEPTOR BLOCKING AGENT;
RITONAVIR;
SEW 2871;
UNCLASSIFIED DRUG;
W 146;
CLINICAL TRIAL;
DATA BASE;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG POTENCY;
DRUG SAFETY;
DRUG SCREENING;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFORMATION TECHNOLOGY;
NOTE;
PATENT;
PRIORITY JOURNAL;
PROFESSIONAL PRACTICE;
PROSTATE CANCER;
PUBLIC HEALTH;
RNA INTERFERENCE;
|
EID: 33751072896
PISSN: 15524450
EISSN: 15524469
Source Type: Journal
DOI: 10.1038/nchembio1206-649 Document Type: Note |
Times cited : (26)
|
References (19)
|